UPA Vaginal Ring
- User: Female
- Hormonal: Hormonal
-
Delivery type:
- Vaginal Ring
-
Intended Duration:
- Short-Acting
- Development Stage: Phase II
- Developer(s)/researcher(s): Population Council, HRA Pharma
Details
- API: Ulipristal Acetate
- Target: Progesterone Receptor
-
Mechanism of Action:
- Ovulation Inhibition
- Cervical Mucus Changes
- Endometrial Changes
- Inactive Materials: Silicone Elastomer
- Regimen: 1 Ring/3 Months
- MPT: Not Potential MPT
Product Status
HRA was acquired and their portfolio de-activated. This product's most recent publications were in 2014.
History
Phase IIa dose-finding study has been completed. Effective dose identified. Additional long-term studies to confirm safety were in preparation when public development stalled around 2014.